Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline

Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org; Practice Committee of the American Society for Reproductive Medicine

doi:10.1016/j.fertnstert.2016.08.048

Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline

Fertil Steril. 2016 Dec;106(7):1634-1647. doi: 10.1016/j.fertnstert.2016.08.048. Epub 2016 Sep 24.

Authors

Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org¹; Practice Committee of the American Society for Reproductive Medicine

Collaborators

Samantha Pfeifer, Samantha Butts, Daniel Dumesic, Gregory Fossum, Clarisa Gracia, Andrew La Barbera, Jennifer Mersereau, Randall Odem, Richard Paulson, Alan Penzias, Margareta Pisarska, Robert Rebar, Richard Reindollar, Mitchell Rosen, Jay Sandlow, Michael Vernon, Eric Widra

Affiliation

¹ American Society for Reproductive Medicine, Birmingham, Alabama.

PMID: 27678032
DOI: 10.1016/j.fertnstert.2016.08.048

Abstract

Ovarian hyperstimulation syndrome (OHSS) is an uncommon but serious complication associated with assisted reproductive technology (ART). This systematic review aims to identify who is at high risk, how to prevent OHSS, and the treatment for existing OHSS.

Publication types

Practice Guideline
Review
Systematic Review

MeSH terms

Female
Humans
Infertility / diagnosis
Infertility / physiopathology
Infertility / therapy*
Ovarian Hyperstimulation Syndrome / chemically induced
Ovarian Hyperstimulation Syndrome / diagnosis
Ovarian Hyperstimulation Syndrome / physiopathology
Ovarian Hyperstimulation Syndrome / prevention & control*
Ovary / drug effects*
Ovary / physiopathology
Ovulation / drug effects*
Ovulation Induction / adverse effects*
Ovulation Induction / standards
Risk Assessment
Risk Factors
Severity of Illness Index
Treatment Outcome